|
|
|
Insider
Information: |
Dallas Jayson Donald Alexander |
Relationship: |
President and CEO, Dir... |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
23,830 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,031,839 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
23,830 |
|
|
Total
Value |
$1,031,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
11.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ultragenyx Pharmaceutical Inc |
RARE |
EVP & Chief Commercial... |
2018-06-01 |
23,830 |
2015-08-04 |
0 |
Premium* |
|
Arena Pharmaceuticals Inc |
ARNA |
Director |
2022-03-11 |
0 |
2018-06-13 |
0 |
Premium* |
|
Aimmune Therapeutics, Inc. |
AIMT |
President and CEO, Dir... |
2020-10-13 |
0 |
2018-06-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2022-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,152) |
0 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2021-06-15 |
4 |
AS |
$66.36 |
$81,158 |
D/D |
(1,223) |
7,152 |
0 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,067 |
8,375 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2021-01-19 |
4 |
AS |
$80.50 |
$106,824 |
D/D |
(1,327) |
5,308 |
0 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2020-12-11 |
4 |
B |
$69.31 |
$347 |
D/D |
5 |
6,635 |
2.31 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2020-12-08 |
4 |
B |
$66.25 |
$331 |
D/D |
5 |
6,630 |
2.31 |
% |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-10-13 |
4 |
D |
$34.50 |
$3,079,125 |
D/D |
(89,250) |
0 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-10-10 |
4 |
D |
$34.50 |
$1,049,559 |
D/D |
(30,422) |
0 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-09-15 |
4 |
D |
$34.25 |
$56,239 |
D/D |
(1,642) |
117,034 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-06-22 |
4 |
D |
$18.02 |
$142,484 |
D/D |
(7,907) |
118,676 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,446 |
6,625 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
126,583 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-03-10 |
4 |
B |
$18.74 |
$49,934 |
D/D |
2,665 |
123,283 |
2.81 |
% |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-03-02 |
4 |
D |
$23.81 |
$73,359 |
D/D |
(3,081) |
120,618 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
123,699 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2019-06-14 |
4 |
AS |
$55.82 |
$85,240 |
D/D |
(1,525) |
4,179 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,654 |
5,704 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
98,650 |
0 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2018-11-19 |
4 |
B |
$27.56 |
$100,587 |
D/D |
3,650 |
63,650 |
2.81 |
- |
|
AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
|
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Director |
|
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,050 |
3,050 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Commercial Officer |
|
2018-06-01 |
4 |
D |
$73.73 |
$21,677 |
D/D |
(294) |
23,830 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Commercial Officer |
|
2018-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,431 |
23,604 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Commercial Officer |
|
2018-03-01 |
4 |
D |
$48.43 |
$21,358 |
D/D |
(441) |
22,173 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Commercial Officer |
|
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
22,614 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|